drugset
drugset / Trial / NCT01036061

GSK618334 Repeat Dose Study

NCT01036061 ↗

Phase 1 Completed 46 enrolled GlaxoSmithKline
RandomizedSingle-groupDouble-blindOther

Summary

The proposed study will evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics of repeated oral doses of GSK618334 in healthy male and female volunteers.

Timeline

Start
2009-09-28
Primary completion
2010-02-17
Completion
2010-02-17

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK618334 Unknown — Oral

Indications

substance dependence